287
Views
14
CrossRef citations to date
0
Altmetric
Drug Profiles

Ibrutinib: a paradigm shift in management of CLL

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Montserrat López-Rubio & Jose Antonio Garcia-Marco. (2015) Current and emerging treatment options for hairy cell leukemia. OncoTargets and Therapy 8, pages 2147-2156.
Read now
Fabio Pagni, Vincenzo L’Imperio, Giovanni Cazzaniga, Lilia Corral, Elisa Doni & Giuseppe Isimbaldi. (2015) Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma. Expert Review of Hematology 8:5, pages 563-565.
Read now

Articles from other publishers (12)

Nazanin Aghel, Rocio C. Baro Vila, Michelle Lui, Christopher Hillis & Darryl P. Leong. (2023) Diagnosis and Management of Cardiovascular Effects of Bruton's Tyrosine Kinase Inhibitors. Current Cardiology Reports 25:9, pages 941-958.
Crossref
Hareem Farooq, Ke Li & Talha Badar. (2023) Aggressive chronic lymphocytic leukemia masked by extensive marrow fibrosis. Leukemia Research Reports 20, pages 100390.
Crossref
Ferenc Takács, Lili Kotmayer, Ágnes Czeti, Gábor Szalóki, Tamás László, Gábor Mikala, Ágnes Márk, András Masszi, Péter Farkas, Márk Plander, Júlia Weisinger, Judit Demeter, Sándor Fekete, László Szerafin, Beáta Margit Deák, Erika Szaleczky, Adrienn Sulák, Zita Borbényi & Gábor Barna. (2022) Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry. Pathology and Oncology Research 28.
Crossref
Ricardo Pineda-Gayoso, Mohammed Alomar, Dae Hyun Lee & Michael G. Fradley. (2020) Cardiovascular Toxicities of Bruton’s Tyrosine Kinase Inhibitors. Current Treatment Options in Oncology 21:8.
Crossref
Federica Barbaglio, Daniela Belloni, Lydia Scarfò, Francesca Vittoria Sbrana, Maurilio Ponzoni, Lucia Bongiovanni, Luca Pavesi, Desiree Zambroni, Kostas Stamatopoulos, Valeria R. Caiolfa, Elisabetta Ferrero, Paolo Ghia & Cristina Scielzo. (2020) Three-dimensional co-culture model of chronic lymphocytic leukemia bone marrow microenvironment predicts patient-specific response to mobilizing agents. Haematologica 106:9, pages 2334-2344.
Crossref
Bola S. Hanna, Haniyeh Yazdanparast, Yasmin Demerdash, Philipp M. Roessner, Ralph Schulz, Peter Lichter, Stephan Stilgenbauer & Martina Seiffert. (2020) Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice. Haematologica 106:4, pages 968-977.
Crossref
Mariana Guarana, Jose Ernesto Vidal & Marcio Nucci. (2018) Cryptococcosis in Patients with Hematologic Diseases. Current Fungal Infection Reports 12:4, pages 187-194.
Crossref
John G. Gribben, Francesc Bosch, Florence Cymbalista, Christian H. Geisler, Paolo Ghia, Peter Hillmen, Carol Moreno & Stephan Stilgenbauer. (2018) Optimising outcomes for patients with chronic lymphocytic leukaemia on ibrutinib therapy: European recommendations for clinical practice. British Journal of Haematology 180:5, pages 666-679.
Crossref
Markus Lindauer & Andreas Hochhaus. 2018. Small Molecules in Hematology. Small Molecules in Hematology 29 68 .
Joseph Justin MulveyGerard J. Nuovo & Cynthia M. Magro. (2016) Cutaneous, Purpuric Painful Nodules Upon Addition of Ibrutinib to RCVP Therapy in a CLL Patient: A Distinctive Reaction Pattern Reflecting Iatrogenic Th2 to Th1 Milieu Reversal. The American Journal of Dermatopathology 38:7, pages 492-498.
Crossref
Nelson Leung & Samih H. Nasr. (2016) A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine. Clinical Journal of the American Society of Nephrology 11:6, pages 1073-1082.
Crossref
Asad Javed, Upasana Joneja, Jerald Z Gong & Guldeep Uppal. (2015) Recent advances in diagnosis and treatment of hairy cell leukemia. International Journal of Hematologic Oncology 4:5, pages 191-200.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.